Overcoming Point-of-Care Friction in TRICARE Access
- Aug 5
- 2 min read
Bottom Line: |
To convert TRICARE coverage into realized commercial volume, pharmaceutical and medical device manufacturers must look beyond formulary placement and actively provide product-specific guidance on how to navigate TRICARE's distinct eligibility, referral, and pre-authorization workflows. |
The TRICARE program covers more than 9.6 million active-duty service members, retirees, and their dependents. For pharmaceutical and medical device manufacturers, this represents a highly stable patient population with unique administrative requirements. To secure therapy adoption and optimize market access, manufacturers must ensure providers are operationally equipped to navigate TRICARE at the point of care. A proper TRICARE strategy often falters at the point of care, where provider administrative staff encounter TRICARE's distinct operational demands. When clinic staff face friction verifying coverage, navigating referrals, or securing pre-authorizations, treatment initiation stalls and prescriptions are abandoned. Manufacturers must proactively eliminate these clinical-level bottlenecks.
To build effective field enablement tools, manufacturers must understand how TRICARE’s three main plan structures impact product delivery:
1. TRICARE Prime: High Control, Referral-Dependent Access
Model: A managed care plan centered on Primary Care Managers to oversee, coordinate, and manage a patient's overall healthcare – most similar to an HMO model.
Key Friction Point: Formal primary care referrals must be issued prior to accessing specialty care, advanced diagnostics, or novel therapies.
Commercial Risk: Administering a specialty product without a valid referral results in rejected claims or significant out-of-pocket expenses, which often leads to therapy discontinuation.
2. TRICARE Select: Preferred Provider Dynamics
Model: Allows flexibility for beneficiaries to see any TRICARE-authorized clinician without requiring specialty referrals—most similar to a PPO model.
Common Friction Point: High-value medical devices and specialty pharmaceuticals still require prior authorizations.
Key Risk: Out-of-network providers failing to collect required pre-authorizations can leave beneficiaries with out-of-pocket costs that destabilize long-term compliance.
3. Specialty Plans (TRICARE For Life, Reserve Components, etc.)
The Model: Segmented coverage based on age, Medicare status, or military service tier (e.g., TRICARE For Life, TRICARE Reserve Select).
Common Friction Point: TRICARE For Life (TFL) acts as a secondary payer to Medicare Parts A and B. Billing sequences must strictly process through Medicare first before rolling over to TRICARE.
Key Risk: Misaligned coordination-of-benefits (COB) processing creates protracted revenue cycle delays for hospital systems, disincentivizing providers from novel devices or therapies.
To transform TRICARE coverage into consistent product adoption, manufacturers must execute a targeted strategy that includes field enablement and administrative support. Manufacturers must integrate specialized TRICARE routing information to support immediate identification of whether a prescribed therapy requires a primary care referral, a preferred provider authorization, or a Medicare-first billing sequence. Teams must be capable of educating provider offices on proper verification protocols. Ensuring clinic staff verify eligibility upfront via the Availity portal using either the patient’s 11-digit DEERS Beneficiary Number (DBN) or 9-digit Social Security Number (SSN)—rather than relying on standard physical credentials—is a best practice.
Reducing operational friction at the clinical level is key in the TRICARE ecosystem. By equipping healthcare providers with operational clarity, manufacturers can protect product adoption and deliver reliable access across the military health system.
